Vimarsana
Biggest News Aggregation in the World

Page 30 - Neurological Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neurological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neurological Sciences Today - Breaking & Trending Today

MEGIN announces sale of TRIUX™ neo to University of Nebraska Medical Center - Vimarsana News

MEGIN announces sale of TRIUX™ neo to University of Nebraska Medical Center

HELSINKI, March 14, 2022 /PRNewswire/ -- MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technol...

MEGIN announces sale of TRIUX™ neo to University of Nebraska Medical Center - Vimarsana News

MEGIN announces sale of TRIUX™ neo to University of Nebraska Medical Center

/PRNewswire/ -- MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, by the University...

Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple SclerosisMonday, March 14th @ 11 am ET, registration details below - Vimarsana News

Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple SclerosisMonday, March 14th @ 11 am ET, registration details below

Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple SclerosisMonday, March 14th @ 11 am ET, registration details below - read this article along with other careers information, tips and advice on BioSpace

Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple Sclerosis - Vimarsana News

Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple Sclerosis

Tiziana Life Sciences Ltd (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, announced today that it will host a virtual Key Opinion Leader (KOL) webinar event, “Foralumab Clinical Update in Multiple Sclerosis: A Landmark ...

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple Sclerosis - Vimarsana News

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple Sclerosis

Monday, March 14th @ 11 am ET, registration details belowNEW YORK, March 11, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling